InvestorsHub Logo
Followers 11
Posts 1538
Boards Moderated 0
Alias Born 08/25/2007

Re: BonelessCat post# 95644

Tuesday, 07/29/2014 8:56:59 PM

Tuesday, July 29, 2014 8:56:59 PM

Post# of 146291
The Ebola program was effective but halted due to funding constraints.

I cant find anywhere confirming your post that it was ineffective.


CAMBRIDGE, MA--(Marketwire - Oct 3, 2012) - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, received notice from the U.S. Department of Defense (DoD) that the Ebola portion of the Company's contract for the advanced development of hemorrhagic fever virus therapeutics was terminated for the convenience of the government due to funding constraints. The DoD's Joint Project Manager Transformational Medical Technologies (JPM-TMT) awarded this contract in July 2010 to advance a platform capability for treating both Marburg virus and Ebola virus. The Marburg portion of the contract remains in effect.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News